Non- or Full-laxative CT Colonography Vs. Endoscopic Tests for Colorectal Cancer Screening: a Randomised Survey Comparing Public Perceptions and Intentions to Undergo Testing
Overview
Affiliations
Objectives: Compare public perceptions and intentions to undergo colorectal cancer screening tests following detailed information regarding CT colonography (CTC; after non-laxative preparation or full-laxative preparation), optical colonoscopy (OC) or flexible sigmoidoscopy (FS).
Methods: A total of 3,100 invitees approaching screening age (45-54 years) were randomly allocated to receive detailed information on a single test and asked to return a questionnaire. Outcomes included perceptions of preparation and test tolerability, health benefits, sensitivity and specificity, and intention to undergo the test.
Results: Six hundred three invitees responded with valid questionnaire data. Non-laxative preparation was rated more positively than enema or full-laxative preparations [effect size (r) = 0.13 to 0.54; p < 0.0005 to 0.036]; both forms of CTC and FS were rated more positively than OC in terms of test experience (r = 0.26 to 0.28; all p-values < 0.0005). Perceptions of health benefits, sensitivity and specificity (p = 0.250 to 0.901), and intention to undergo the test (p = 0.213) did not differ between tests (n = 144-155 for each test).
Conclusions: Despite non-laxative CTC being rated more favourably, this study did not find evidence that offering it would lead to substantially higher uptake than full-laxative CTC or other methods. However, this study was limited by a lower than anticipated response rate.
Key Points: • Improving uptake of colorectal cancer screening tests could improve health benefits • Potential invitees rate CTC and flexible sigmoidoscopy more positively than colonoscopy • Non-laxative bowel preparation is rated better than enema or full-laxative preparations • These positive perceptions alone may not be sufficient to improve uptake • Health benefits and accuracy are rated similarly for preventative screening tests.
Winters C, Subramanian V, Valdastri P World J Gastroenterol. 2022; 28(35):5093-5110.
PMID: 36188716 PMC: 9516669. DOI: 10.3748/wjg.v28.i35.5093.
Von Wagner C, Verstraete W, Hirst Y, Nicholson B, Stoffel S, Laszlo H BJGP Open. 2020; 4(1).
PMID: 32019773 PMC: 7330201. DOI: 10.3399/bjgpopen20X101007.
Zhu H, Li F, Tao K, Wang J, Scurlock C, Zhang X Br J Radiol. 2019; 93(1105):20190240.
PMID: 31651188 PMC: 6948079. DOI: 10.1259/bjr.20190240.
Sali L, Ventura L, Grazzini G, Borgheresi A, Delsanto S, Falchini M Eur Radiol. 2018; 29(5):2457-2464.
PMID: 30402705 DOI: 10.1007/s00330-018-5808-1.
Duarte R, Bernardo W, Sakai C, Silva G, Guedes H, Kuga R Ther Clin Risk Manag. 2018; 14:349-360.
PMID: 29503554 PMC: 5826249. DOI: 10.2147/TCRM.S152147.